Skip to content
healthcare.dev

Memantine Hydrochloride

NDC 70436-054, memantine hydrochloride, capsule, extended release, from Slate Run Pharmaceuticals, LLC.

Product NDC
70436-054
Status
Listed
Labeler
Slate Run Pharmaceuticals, LLC
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211100
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70436-054 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MEMANTINE HYDROCHLORIDE7 mg/1

Pharmacologic classes

N-methyl-D-aspartate Receptor Antagonist [EPC]; NMDA Receptor Antagonists [MoA]

Package NDCNDC-11Package
70436-054-047043600540430 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70436-054-04)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a74050c4-5a37-4fa1-85d9-85831525cfeb
  • NADAC price for package 70436005404

    GET /v1/drugs/nadac/70436005404

Use it

Look up 70436-054 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70436-054 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70436-054. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.